Christopher Baum

发表

Estimating a dose-response function with heterogeneous response to confounders when treatment is continuous and endogenous

Christopher Baum, CNR-IRCrES Giovanni Cerulli, 2016 .

Self-inactivating retroviral vectors for gene therapy of SCID-X1

Simon N. Waddington, Christine Kinnon, Aj Thrasher, 2008 .

Assessing genotoxicity of lenti- and gammaretroviral vectors in vitro

Christopher Baum, Ute Modlich, S Knoss, 2009 .

Development of Gene Therapy for HLH Due to Perforin Deficiency

Christopher Baum, Adrian J. Thrasher, Axel Schambach, 2010 .

Artemis and ligase 4 are dispensable for the generation of human induced pluripotent stem cells

Christopher Baum, T Matzig, Axel Schambach, 2012 .

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Hung Fan, Alessandro Aiuti, Jacqueline Corrigan-Curay, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Overexpression of MDR1 Using a Retroviral Vector Differentially Regulates Genes Involved in Detoxification and Apoptosis and Confers Radioprotection

Stefan Fruehauf, Li Li, Christopher Baum, 2006, Radiation research.

Limited complementarity between U1 snRNA and a retroviral 5′ splice site permits its attenuation via RNA secondary structure

Christopher Baum, Daniela Zychlinski, Heiner Schaal, 2009, Nucleic acids research.

Gene Therapy--New Challenges Ahead

Christopher Baum, David A. Williams, David A. Williams, 2003, Science.

and insertional genotoxicity Cell culture assays reveal the importance of retroviral vector design for

Christof von Kalle, Christopher Baum, Ute Modlich, 2006 .

Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

Renate Kunert, Christopher Baum, R. Kunert, 2004, Journal of Virology.

Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Christopher Baum, Axel Schambach, Timm Schroeder, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.

Felix Hermann, Christopher Baum, J. van Lunzen, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides.

Christopher Baum, Ursula Dietrich, U. Dietrich, 2008, Human gene therapy.

Side effects of retroviral gene transfer into hematopoietic stem cells.

Christof von Kalle, Christopher Baum, David A. Williams, 2003, Blood.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

Christopher Baum, David A. Williams, Gregory Hopkins, 2014, The New England journal of medicine.